TITLE

HMS Holdings Corp Reports 1st Qtr 2012 Results

PUB. DATE
April 2012
SOURCE
Biomedical Market Newsletter;4/28/2012, Vol. 21, p1
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article provides information on the financial results of HMS Holdings Corp. for the first quarter ended March 31, 2012. It indicates that total revenue for the first quarter of 2012 was 107.3 million U.S. dollars compared to 82.5 million dollars in same period during 2011. The company also reported adjusted EPS of 0.16 dollars in the first quarter of 2012 and a net income of 7.0 million dollars.
ACCESSION #
76119458

 

Related Articles

  • Celgene Reports 1st Qtr 2012 Operating and Financial Results.  // Biomedical Market Newsletter;4/28/2012, Vol. 21, p1 

    The article provides information on the financial results of Celgene Corp. for the first quarter ended March 31, 2012. It indicates that non-GAAP net product sales for the first quarter of 2012 were 1,245 million U.S. dollars compared. The company also reported net income of 484 million dollars...

  • Healthy living pays fat dividend for NBTY as shares more than double in a year.  // Crain's New York Business;11/20/2006, Vol. 22 Issue 47, p4 

    The article states that nutritional supplement maker, distributor and marketer NBTY Inc. in November 2006 reported a quarterly profit of 54 cents a share, beating Wall Street forecasts by 35%. The earnings helped send the company's stock up 17%, pushing the year-to-date gain to over 100%. The...

  • Pall Corp Reports Third Quarter Results.  // Biomedical Market Newsletter;6/7/2012, Vol. 21, p1 

    The article informs that Pall Corp. has released its financial results for the third quarter of fiscal year 2012 ended April 30, 2012 along with corporate highlights. It informs that the third quarter sales reported an increase of one percent with diluted earning per share (EPS) being 0.67 U.S....

  • Forest Laboratories Inc. Reports FY 4th Qtr 2012 Earnings Per Share of $0.72 Including $0.06 Per Share of Acquisition Amortization.  // Biomedical Market Newsletter;4/21/2012, Vol. 21, p1 

    The article provides information on the financial results of Forest Laboratories Inc. for the fourth quarter of 2012. It indicates that earnings per share equaled 0.72 U.S. dollar in the fourth quarter of fiscal year 2012 compared to 1.12 dollar in 2011. The company also reported net sales of...

  • RTI Biologics Announces 2012 1st Qtr Results.  // Biomedical Market Newsletter;4/28/2012, Vol. 21, p1 

    The article provides information on the financial results of RTI Biologics Inc. for the first quarter ended March 31, 2012. It indicates that total revenue for the first quarter of 2012 was 43.7 million U.S. dollars and the net income was two million dollars. The company also reported quarterly...

  • Thermo Fisher Scientific Reports 2nd Quarter 2012 Results.  // Biomedical Market Newsletter;7/26/2012, Vol. 21, p1 

    The article informs that Thermo Fisher Scientific Inc. has reported its financial results for the 2nd quarter ended June 30, 2012. It mentions that adjusted earnings per share have increased to a 2nd quarter record of 1.22 U.S. dollars while the revenue increased to the same period record of...

  • HMS Holdings Corp. Announces 2nd Quarter 2012 Financial and Operating Results.  // Biomedical Market Newsletter;8/7/2012, Vol. 21, p1 

    The article offers information on the release of financial results by HMS Holdings Corp. for second quarter of 2012. The revenues generated by the company increased by 34.4 percent with total of 120.1 million dollars. The company earned operating income of 13 million dollars with rise in diluted...

  • Expedia Q3 Earnings Beat, Revenue Lags. MAX A. CHERNEY // Investors Business Daily;10/29/2015, p00 

    The article reports on the mixed third quarter earnings of online travel company Expedia which is the first financial report since its acquisition of the rival agency Orbitz on September 17, 2015. Topics mentioned include the reported increase of the earnings per share, the comment of chief...

  • Biotage: Interim Report Jan - June 2012.  // Biomedical Market Newsletter;8/28/2012, Vol. 21, p1 

    The article presents interim report of the company Biotage for the period from January-June 2012. It reports that in the second quarter from April-June 2012, the net sales increased by 24 percent with earnings per share amounting to 0.18 Swedish krona (SEK). For the first six months from...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics